Gemphire Therapeutics IPO Research Information

Gemphire Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Gemphire Therapeutics , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Gemphire Therapeutics	GEMP - NASDAQ	$11.00-$13.00	$10.00	$9.25	3 million	8/5/2016
Underwriter(s): Jefferies, RBC Capital Markets
Co-Manager(s): Canaccord Genuity, Roth Capital Partners
Industry: Health Care
Filing(s): Filed 2016-04-18 Terms Added 2016-06-13

Gemphire Therapeutics Quote & Chart - Click for current quote - GEMP

About Gemphire Therapeutics (adapted from Gemphire Therapeutics prospectus):
They are a cardiovascular biotech developing therapies for the treatment of dyslipidemia.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "GEMP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.